200 related articles for article (PubMed ID: 36109341)
21. Continuous multi-column capture of monoclonal antibodies with convective diffusive membrane adsorbers.
Schmitz F; Knöchelmann E; Kruse T; Minceva M; Kampmann M
Biotechnol Bioeng; 2024 Jun; 121(6):1859-1875. PubMed ID: 38470343
[TBL] [Abstract][Full Text] [Related]
22. "Organized stress" for robust scale-up of intensified production process with fed-batch seed bioreactor.
Ben Yahia B; Piednoir A; Dahomais T; Eggermont S; Paul W
Biotechnol Bioeng; 2023 Sep; 120(9):2509-2522. PubMed ID: 37027375
[TBL] [Abstract][Full Text] [Related]
23. Complete or periodic continuity in continuous manufacturing platforms for production of monoclonal antibodies?
Kateja N; Tiwari A; Thakur G; Rathore AS
Biotechnol J; 2021 Jul; 16(7):e2000524. PubMed ID: 33773062
[TBL] [Abstract][Full Text] [Related]
24. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
[TBL] [Abstract][Full Text] [Related]
25. Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up.
Girard V; Hilbold NJ; Ng CK; Pegon L; Chahim W; Rousset F; Monchois V
J Biotechnol; 2015 Nov; 213():65-73. PubMed ID: 25962790
[TBL] [Abstract][Full Text] [Related]
26. WAVE-based intensified perfusion cell culture for fast process development.
Lang Z; Yan S; Xiong Q; Chen G
Biotechnol Lett; 2023 Sep; 45(9):1117-1131. PubMed ID: 37382759
[TBL] [Abstract][Full Text] [Related]
27. Economics and ecology: Modelling of continuous primary recovery and capture scenarios for recombinant antibody production.
Cataldo AL; Burgstaller D; Hribar G; Jungbauer A; Satzer P
J Biotechnol; 2020 Jan; 308():87-95. PubMed ID: 31809781
[TBL] [Abstract][Full Text] [Related]
28. Continuous and Integrated Expression and Purification of Recombinant Antibodies.
Vogg S; Wolf MKF; Morbidelli M
Methods Mol Biol; 2018; 1850():147-178. PubMed ID: 30242686
[TBL] [Abstract][Full Text] [Related]
29. Integrated continuous biomanufacturing on pilot scale for acid-sensitive monoclonal antibodies.
Schwarz H; Gomis-Fons J; Isaksson M; Scheffel J; Andersson N; Andersson A; Castan A; Solbrand A; Hober S; Nilsson B; Chotteau V
Biotechnol Bioeng; 2022 Aug; 119(8):2152-2166. PubMed ID: 35470430
[TBL] [Abstract][Full Text] [Related]
30. Upstream continuous processing: recent advances in production of biopharmaceuticals and challenges in manufacturing.
Matanguihan C; Wu P
Curr Opin Biotechnol; 2022 Dec; 78():102828. PubMed ID: 36332340
[TBL] [Abstract][Full Text] [Related]
31. Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE Bioreactor™-part II: Applications for antibody production and cryopreservation.
Clincke MF; Mölleryd C; Samani PK; Lindskog E; Fäldt E; Walsh K; Chotteau V
Biotechnol Prog; 2013; 29(3):768-77. PubMed ID: 23436783
[TBL] [Abstract][Full Text] [Related]
32. Fully integrated downstream process to enable next-generation manufacturing.
Ramos I; Sharda N; Villafana R; Hill-Byrne K; Cai K; Pezzini J; Coffman J
Biotechnol Bioeng; 2023 Jul; 120(7):1869-1881. PubMed ID: 36950907
[TBL] [Abstract][Full Text] [Related]
33. Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch.
Särnlund S; Jiang Y; Chotteau V
Biotechnol Bioeng; 2021 Sep; 118(9):3533-3544. PubMed ID: 33914903
[TBL] [Abstract][Full Text] [Related]
34. Improved protein A resin for antibody capture in a continuous countercurrent tangential chromatography system.
Fedorenko D; Dutta AK; Tan J; Walko J; Brower M; Pinto NDS; Zydney AL; Shinkazh O
Biotechnol Bioeng; 2020 Mar; 117(3):646-653. PubMed ID: 31784975
[TBL] [Abstract][Full Text] [Related]
35. Risk assessment for biopharmaceutical single-use manufacturing: A case study of upstream continuous processing.
Ito T; Wang H; Hwang SH; Wang B; Wang L; G S
Biologicals; 2023 Nov; 84():101713. PubMed ID: 37793309
[TBL] [Abstract][Full Text] [Related]
36. Impact of micro and macroporous TFF membranes on product sieving and chromatography loading for perfusion cell culture.
Pinto NDS; Napoli WN; Brower M
Biotechnol Bioeng; 2020 Jan; 117(1):117-124. PubMed ID: 31612989
[TBL] [Abstract][Full Text] [Related]
37. Integrated Process Analytical Platform for Automated Monitoring of Monoclonal Antibody N-Linked Glycosylation.
Gyorgypal A; Chundawat SPS
Anal Chem; 2022 May; 94(19):6986-6995. PubMed ID: 35385654
[TBL] [Abstract][Full Text] [Related]
38. A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.
Janoschek S; Schulze M; Zijlstra G; Greller G; Matuszczyk J
Biotechnol Prog; 2019 Mar; 35(2):e2757. PubMed ID: 30479066
[TBL] [Abstract][Full Text] [Related]
39. An automated high inoculation density fed-batch bioreactor, enabled through N-1 perfusion, accommodates clonal diversity and doubles titers.
Olin M; Wolnick N; Crittenden H; Quach A; Russell B; Hendrick S; Armstrong J; Webster T; Hadley B; Dickson M; Hodgkins J; Busa K; Connolly R; Downey B
Biotechnol Prog; 2024; 40(2):e3410. PubMed ID: 38013663
[TBL] [Abstract][Full Text] [Related]
40. Scale-up of continuous multicolumn chromatography for the protein a capture step: From bench to clinical manufacturing.
Ötes O; Flato H; Vazquez Ramirez D; Badertscher B; Bisschops M; Capito F
J Biotechnol; 2018 Sep; 281():168-174. PubMed ID: 30025795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
